Champions Oncology (CSBR) Gross Profit Growth (3y) (2013 - 2026)
Champions Oncology (CSBR) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
411.41% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
7.16% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Champions Oncology |
82.77 Mn |
75.76 Mn |
13.89 Mn |
8.05% |
| Date | Value |
|---|
| Jan 31, 2026 |
8.05% |
| Oct 31, 2025 |
4.36% |
| Jul 31, 2025 |
21.95% |
| Apr 30, 2025 |
41.76% |
| Jan 31, 2025 |
-3.63% |
| Oct 31, 2024 |
-15.78% |
| Jul 31, 2024 |
6.07% |
| Apr 30, 2024 |
47.35% |
| Jan 31, 2024 |
3.13% |
| Oct 31, 2023 |
3.47% |
| Jul 31, 2023 |
-16.37% |
| Apr 30, 2023 |
-29.65% |
| Jan 31, 2023 |
12.64% |
| Oct 31, 2022 |
0.94% |
| Jul 31, 2022 |
30.89% |
| Apr 30, 2022 |
-34.07% |
| Jan 31, 2022 |
57.14% |
| Oct 31, 2021 |
46.27% |
| Jul 31, 2021 |
23.07% |
| Apr 30, 2021 |
29.22% |
